A phase II study of etoposide, methylprednisolone, high-dose cytarabine, and oxaliplatin (ESHAOx) for patients with refractory or relapsed Hodgkin’s lymphoma
Won, Young-Woong, Lee, Hyewon, Eom, Hyeon-Seok, Kim, Jin Seok, Suh, Cheolwon, Yoon, Dok Hyun, Hong, Jung Yong, Kang, Hye Jin, Lee, Jae Hoon, Kim, Won Seog, Kim, Seok Jin, Lee, Won-Sik, Chang, Myung HeJournal:
Annals of Hematology
DOI:
10.1007/s00277-019-03891-9
Date:
January, 2020
File:
PDF, 488 KB
2020